• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort.

作者信息

Al Arashi Wala, Iñiguez Ubiaga Carlota, Hensor Elizabeth M, Gaffney Katie, Freeston Jane, Vandevelde Claire, Barr Andrew, van der Horst-Bruinsma Irene, Marzo-Ortega Helena

机构信息

Department of Rheumatology, NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust.

Department of Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

出版信息

Rheumatol Adv Pract. 2018 Oct 18;2(2):rky036. doi: 10.1093/rap/rky036. eCollection 2018.

DOI:10.1093/rap/rky036
PMID:31433400
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6649944/
Abstract
摘要

相似文献

1
Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort.评论：肿瘤坏死因子抑制剂在轴性脊柱关节炎中的生存情况及反应预测因素——来自英国队列的研究结果
Rheumatol Adv Pract. 2018 Oct 18;2(2):rky036. doi: 10.1093/rap/rky036. eCollection 2018.
2
Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort: reply.
Rheumatol Adv Pract. 2018 Oct 18;2(2):rky037. doi: 10.1093/rap/rky037. eCollection 2018.
3
Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort.肿瘤坏死因子抑制剂在中轴型脊柱关节炎中的生存和反应预测因素：来自英国队列的研究结果。
Rheumatology (Oxford). 2018 Apr 1;57(4):619-624. doi: 10.1093/rheumatology/kex457.
4
Similarities and differences between nonradiographic and radiographic axial spondyloarthritis: a clinical, epidemiological and therapeutic assessment.非放射学性与放射学性轴性脊柱关节炎之间的异同：一项临床、流行病学及治疗评估
Curr Opin Rheumatol. 2014 Jul;26(4):377-83. doi: 10.1097/BOR.0000000000000071.
5
Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis.切换肿瘤坏死因子抑制剂治疗中轴型脊柱关节炎。
Semin Arthritis Rheum. 2017 Dec;47(3):343-350. doi: 10.1016/j.semarthrit.2017.04.005. Epub 2017 Apr 25.
6
Predictors of Assessment of Spondyloarthritis International Society (ASAS) Health Index in Axial Spondyloarthritis and Comparison of ASAS Health Index between Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Data from the Catholic Axial Spondyloarthritis COhort (CASCO).轴性脊柱关节炎中脊柱关节炎国际协会（ASAS）健康指数的预测因素以及强直性脊柱炎与非放射学轴性脊柱关节炎之间ASAS健康指数的比较：来自天主教轴性脊柱关节炎队列（CASCO）的数据
J Clin Med. 2019 Apr 5;8(4):467. doi: 10.3390/jcm8040467.
7
Efficacy and drug survival of anti-tumour necrosis factor-alpha therapies in patients with non-radiographic axial spondyloarthritis: an observational cohort study from Southern Sweden.抗肿瘤坏死因子-α疗法在非放射学轴性脊柱关节炎患者中的疗效及药物留存率：一项来自瑞典南部的观察性队列研究
Scand J Rheumatol. 2014;43(6):493-7. doi: 10.3109/03009742.2014.918173. Epub 2014 Aug 22.
8
Comparative Analysis and Predictors of 10-year Tumor Necrosis Factor Inhibitors Drug Survival in Patients with Spondyloarthritis: First-year Response Predicts Longterm Drug Persistence.强直性脊柱炎患者 10 年肿瘤坏死因子抑制剂药物生存的比较分析和预测因素：第一年的反应预测长期药物维持。
J Rheumatol. 2018 Jun;45(6):785-794. doi: 10.3899/jrheum.170477. Epub 2018 Apr 1.
9
Axial spondyloarthritis.中轴型脊柱关节炎。
Nat Rev Dis Primers. 2015 Jul 9;1:15013. doi: 10.1038/nrdp.2015.13.
10
Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis.吸烟的中轴型脊柱关节炎患者对肿瘤坏死因子 α 抑制剂治疗反应受损。
Ann Rheum Dis. 2016 Mar;75(3):532-9. doi: 10.1136/annrheumdis-2013-205133. Epub 2015 Feb 9.

引用本文的文献

1
Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data.接受乌司奴单抗或肿瘤坏死因子抑制剂治疗的银屑病关节炎患者的性别特异性差异：真实世界数据。
Rheumatology (Oxford). 2023 Oct 3;62(10):3382-3390. doi: 10.1093/rheumatology/kead089.
2
Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis.轴向型脊柱关节炎的患病率、表现和结局的性别二态性。
Nat Rev Rheumatol. 2022 Nov;18(11):657-669. doi: 10.1038/s41584-022-00833-0. Epub 2022 Sep 15.
3
Sex and gender differences in axial spondyloarthritis: myths and truths.

本文引用的文献

1
Gender Differences in Axial Spondyloarthritis: Women Are Not So Lucky.性别差异与中轴型脊柱关节炎：女性并非如此“幸运”。
Curr Rheumatol Rep. 2018 May 12;20(6):35. doi: 10.1007/s11926-018-0744-2.
2
Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort.男性和女性强直性脊柱炎患者对肿瘤坏死因子抑制的反应：来自瑞士队列的数据。
J Rheumatol. 2018 Apr;45(4):506-512. doi: 10.3899/jrheum.170166. Epub 2018 Feb 15.
3
Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort.
性别与中轴型脊柱关节炎：误区与真相。
Rheumatology (Oxford). 2020 Oct 1;59(Suppl4):iv38-iv46. doi: 10.1093/rheumatology/keaa543.
4
Comment on: Tumour necrosis factor inhibitor survival and predictors of response in axial spondyloarthritis-findings from a United Kingdom cohort: reply.
Rheumatol Adv Pract. 2018 Oct 18;2(2):rky037. doi: 10.1093/rap/rky037. eCollection 2018.
肿瘤坏死因子抑制剂在中轴型脊柱关节炎中的生存和反应预测因素：来自英国队列的研究结果。
Rheumatology (Oxford). 2018 Apr 1;57(4):619-624. doi: 10.1093/rheumatology/kex457.
4
Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studies.女性强直性脊柱炎患者：治疗研究中跨性别影响的分析。
Ann Rheum Dis. 2013 Jul;72(7):1221-4. doi: 10.1136/annrheumdis-2012-202431. Epub 2012 Dec 22.
5
Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registry.432 例强直性脊柱炎患者转换肿瘤坏死因子 α 抑制剂治疗后的临床应答、药物存活及相关预测因素：来自丹麦全国性 DANBIO 登记处的数据。
Ann Rheum Dis. 2013 Jul;72(7):1149-55. doi: 10.1136/annrheumdis-2012-201933. Epub 2012 Aug 31.
6
Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study.强直性脊柱炎肿瘤坏死因子-α阻断治疗应答和停药的基线预测因素：一项前瞻性纵向观察队列研究。
Arthritis Res Ther. 2011 Jun 20;13(3):R94. doi: 10.1186/ar3369.
7
Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort.强直性脊柱炎的严重程度是否存在性别差异？来自腰大肌队列研究的结果。
Ann Rheum Dis. 2007 May;66(5):633-8. doi: 10.1136/ard.2006.060293. Epub 2006 Nov 24.
8
The interrelationship between sex, susceptibility factors, and outcome in ankylosing spondylitis and its associated disorders including inflammatory bowel disease, psoriasis, and iritis.强直性脊柱炎及其相关疾病（包括炎症性肠病、银屑病和虹膜炎）中性别、易患因素与结局之间的相互关系。
J Rheumatol. 2003 Sep;30(9):2054-8.